$4.56 Billion is the total value of Glenview Capital Management's 54 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 71.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | Buy | SPDR S&P 500 ETF TRput | $491,022,366 | +78.6% | 1,199,400 | +66.8% | 10.77% | +76.9% |
CI | Buy | THE CIGNA GROUP | $472,892,250 | -22.4% | 1,850,633 | +0.6% | 10.38% | -23.2% |
VVV | Buy | VALVOLINE INC | $132,875,038 | +16.5% | 3,802,949 | +8.9% | 2.92% | +15.4% |
ALIT | Buy | ALIGHT INC | $130,271,683 | +99.1% | 14,144,591 | +80.7% | 2.86% | +97.1% |
HCA | Buy | HCA HEALTHCARE INC | $119,243,215 | +12.9% | 452,227 | +2.8% | 2.62% | +11.8% |
CLVT | Buy | CLARIVATE PLC | $109,192,207 | +29.9% | 11,628,563 | +15.4% | 2.40% | +28.7% |
APTV | Buy | APTIV PLC | $104,666,651 | +22.0% | 932,941 | +1.3% | 2.30% | +20.8% |
CTVA | Buy | CORTEVA INC | $98,860,634 | +147.5% | 1,639,208 | +141.2% | 2.17% | +145.1% |
FMC | Buy | FMC CORP | $98,029,599 | +8.8% | 802,666 | +11.2% | 2.15% | +7.8% |
MYGN | Buy | MYRIAD GENETICS INC | $97,452,452 | +116.8% | 4,195,112 | +35.4% | 2.14% | +114.7% |
DD | Buy | DUPONT DE NEMOURS INC | $87,348,109 | +11.2% | 1,217,056 | +6.3% | 1.92% | +10.1% |
LII | Buy | LENNOX INTL INC | $59,761,671 | +41.6% | 237,829 | +34.8% | 1.31% | +40.2% |
BKD | Buy | BROOKDALE SR LIVING INC | $55,001,785 | +45.5% | 18,644,673 | +34.7% | 1.21% | +44.2% |
NSC | Buy | NORFOLK SOUTHN CORP | $54,156,460 | -3.4% | 255,455 | +12.2% | 1.19% | -4.3% |
AMZN | New | AMAZON COM INC | $46,967,822 | – | 454,718 | +100.0% | 1.03% | – |
ABC | Buy | AMERISOURCEBERGEN CORP | $44,449,418 | +6204.0% | 277,618 | +6424.5% | 0.98% | +5993.8% |
BABA | Buy | ALIBABA GROUP HLDG LTDsponsored ads | $41,184,977 | +36.0% | 403,063 | +17.2% | 0.90% | +34.7% |
AVTR | New | AVANTOR INC | $39,379,592 | – | 1,862,800 | +100.0% | 0.86% | – |
FDX | New | FEDEX CORP | $37,148,590 | – | 162,583 | +100.0% | 0.82% | – |
DVA | New | DAVITA INC | $22,400,554 | – | 276,175 | +100.0% | 0.49% | – |
KNX | New | KNIGHT-SWIFT TRANSN HLDGS INcl a | $21,299,541 | – | 376,450 | +100.0% | 0.47% | – |
Buy | EVOLV TECHNOLOGIES HLDNGS IN | $19,708,647 | +27.3% | 6,316,874 | +5.6% | 0.43% | +25.9% | |
MTCH | New | MATCH GROUP INC NEW | $18,230,874 | – | 474,886 | +100.0% | 0.40% | – |
New | BROOKDALE SR LIVING INCnote 2.000%10/1 | $18,194,078 | – | 25,450,000 | +100.0% | 0.40% | – | |
UNH | New | UNITEDHEALTH GROUP INC | $17,351,614 | – | 36,716 | +100.0% | 0.38% | – |
BFLY | Buy | BUTTERFLY NETWORK INC | $15,102,982 | +12.3% | 8,033,501 | +47.0% | 0.33% | +11.1% |
UNP | New | UNION PAC CORP | $12,579,555 | – | 62,504 | +100.0% | 0.28% | – |
LH | New | LABORATORY CORP AMER HLDGS | $11,563,227 | – | 50,402 | +100.0% | 0.25% | – |
CAH | New | CARDINAL HEALTH INC | $10,647,916 | – | 141,032 | +100.0% | 0.23% | – |
SABR | Buy | SABRE CORP | $9,439,707 | +34.4% | 2,200,398 | +93.6% | 0.21% | +32.7% |
ANTM | New | ELEVANCE HEALTH INC | $5,456,565 | – | 11,867 | +100.0% | 0.12% | – |
BLI | Buy | PHENOMEX INC | $4,426,923 | -36.7% | 3,816,313 | +46.2% | 0.10% | -37.4% |
Buy | RAPID MICRO BIOSYSTEMS INC | $1,071,957 | +17.1% | 818,288 | +1.0% | 0.02% | +20.0% | |
CANO | New | CANO HEALTH INC | $864,616 | – | 950,127 | +100.0% | 0.02% | – |
BFLYWS | New | BUTTERFLY NETWORK INC*w exp 02/12/202 | $455,918 | – | 1,713,333 | +100.0% | 0.01% | – |
New | DOMA HOLDINGS INC | $203,750 | – | 500,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
About Glenview Capital Management
Glenview Capital Management is a well-known investment management firm that was founded in 2001 by Larry Robbins. The company is headquartered in New York City and manages over $10 billion in assets. Glenview Capital Management is known for its long-term investment strategy and its focus on fundamental analysis. The company invests in a wide range of industries, including healthcare, technology, and consumer goods.
Larry Robbins, the CEO and founder of Glenview Capital Management, is a well-respected figure in the finance industry. He has been recognized for his investment expertise and has been featured in numerous publications, including Forbes and The Wall Street Journal. In addition to Robbins, Glenview Capital Management has a team of experienced professionals, including COO Mark Horowitz and Chief Investment Officer Lee Ainslie.
Glenview Capital Management has a strong track record of delivering solid returns to its investors. The company's investment philosophy is centered around identifying undervalued companies with strong fundamentals and holding them for the long-term. This approach has proven successful, as Glenview Capital Management has consistently outperformed the market over the years.
Overall, Glenview Capital Management is a reputable investment management firm with a strong team of professionals and a proven investment strategy. While past performance is not indicative of future results, investors looking for a long-term investment strategy may want to consider Glenview Capital Management as a potential investment option.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TENET HEALTHCARE CORP | 42 | Q3 2023 | 16.7% |
HCA HOLDINGS INC | 42 | Q3 2023 | 9.1% |
MCKESSON CORP | 40 | Q3 2023 | 8.2% |
FLEXTRONICS INTL LTD | 38 | Q2 2023 | 4.5% |
BROOKDALE SR LIVING INC | 38 | Q3 2023 | 2.1% |
MERITOR INC | 36 | Q1 2022 | 3.0% |
FMC CORP | 34 | Q2 2023 | 6.4% |
UNIVERSAL HLTH SVCS INC | 34 | Q3 2023 | 5.0% |
HUMANA INC | 31 | Q4 2021 | 12.1% |
ENDO INTL PLC | 30 | Q1 2022 | 2.8% |
View Glenview Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Butterfly Network, Inc. | February 14, 2023 | 9,746,834 | 5.5% |
Quantum-Si Inc | February 14, 2023 | 4,249,956 | 3.6% |
MERITOR, INC. | February 22, 2022 | 3,544,333 | 5.0% |
ATI Physical Therapy, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
Evolv Technologies Holdings, Inc. | February 14, 2022 | 749,461 | 0.5% |
Velocity Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
Bausch Health Companies Inc. | December 13, 2021 | 17,078,657 | 4.8% |
NewHold Investment Corp. | June 04, 2021 | 1,114,862 | 6.5% |
Longview Acquisition Corp. II | April 02, 2021 | 5,000,000 | 7.2% |
HighCape Capital Acquisition Corp. | March 15, 2021 | 1,033,739 | 8.7% |
View Glenview Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-01-16 |
13F-HR | 2023-11-14 |
SC 13G | 2023-11-13 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
View Glenview Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.